Plasminogen Activator Inhibitor-1 Is Involved in Streptozotocin-Induced Bone Loss in Female Mice

(Downloading may take up to 30 seconds. If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.

FIG. 7.
FIG. 7.

Effect of insulin treatment on streptozotocin-induced bone loss in female mice. The levels of plasma PAI-1 (A) and PAI-1 mRNA in liver (B), BMDs (total, trabecular, and cortical), and bone strength index in tibia (C) in control female mice and diabetic female mice treated with or without insulin for 4 weeks. Results are expressed relative to β-actin mRNA values and expressed as means ± SEM. **P < 0.01 (n = 6 in each group). Proposed hypothesis for the role of PAI-1 in the pathogenesis of diabetic osteoporosis in female mice (D): Diabetic state induces an increase in PAI-1 expression in the liver, resulting in an elevation of circulating PAI-1 levels in female mice. An elevated circulating PAI-1 impairs osteoblast differentiation and mineralization. Furthermore, it promotes adipogenesis in bone tissues. These cascades may lead to diabetic osteoporosis in female mice.

This Article

  1. Diabetes vol. 62 no. 9 3170-3179